Zus Health, Inc.

Zus Health, Inc. is a US-based company that offers a pioneering shared health data platform designed to enhance healthcare interoperability, enabling efficient access to patient histories and care needs for healthcare teams. Founded in 2020 and headquartered in Watertown, US, Zus Health specializes in creating shared health data solutions. The company completed its most recent funding round, a SERIES A, on February 22, 2023, raising USD 28.

27 mn from investors including Andreessen Horowitz, F-Prime Capital, and Maverick Ventures. The founders of Zus Health include Ada Glover, Duke Rohlen, Philip Wickline, and Tim Gorton, with Duke Rohlen also serving as the CEO. The total amount raised by the company to date is USD 28. 27 mn, and its current valuation stands at USD 168.

465 mn. Zus Health offers a next-generation shared health data platform with its core product, the Zus Aggregated Profile (ZAP). This tool provides a comprehensive overview of patient interactions, facilitating efficient access for healthcare teams to patient histories and ongoing care needs. The ZAP enhances healthcare interoperability and is accessible via standalone apps, APIs, embedded components, and direct EHR integrations.

Key users include hospitals, telehealth providers, and chronic care management companies, all leveraging the ZAP to improve care coordination and patient outcomes. Zus Health primarily generates revenue through subscription-based models, partnerships, and B2B transactions. Healthcare organizations and technology partners subscribe to the ZAP and related services, gaining access to real-time patient data and analytics. The company's subscription plans are tiered to meet the varying needs of organizations, allowing seamless integration of Zus Health's tools into existing workflows, thereby fostering improved patient management and operational efficiencies.

In February 2023, Zus Health raised USD 28. 27 mn in venture funding to enhance its platform's workflow and incorporate additional data sources. The company aims to develop new product offerings and expand its reach into additional geographic markets, focusing on areas where innovative patient data management solutions are required. Specific details regarding product launches and regional expansions have yet to be outlined, but the recent funding will bolster these initiatives.